Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies
Patricia Parris, Elizabeth A. Martin, Brad Stanard, Susanne Glowienke, David G. Dolan, Kim Li, Ornella Binazon, Amanda Giddings, Geraldine Whelan, Melisa Masuda-Herrera, Joel P. Bercu, Thomas H. Broschard, Uma Bruen, Courtney M. Callis, Cheryl L. M. Stults, Gregory L. Erexson, Maureen T. Cruz, Lee M. Nagao
Topics & Concepts
Risk analysis (engineering)Biochemical engineeringComputer scienceToxicologyMedicineEngineeringBiologyEffects and risks of endocrine disrupting chemicalsSafe Handling of Antineoplastic DrugsPharmaceutical studies and practices